Expert Interview
Discussing the recent data presented at AACR 2025 on adding Perioperative Pembrolizumab to Standard of Care in Patients With Newly Diagnosed Head and Neck Cancer
Ticker(s): MRKInstitution: Florida Cancer Specialists
- Medical Oncologist and Director of Drug Development at Florida Cancer Specialists.
- Specializes in experimental therapeutics for head, neck and thoracic medical oncology.
- Previously served as an Associate Professor of Medicine at the University of Miami where he was a leader for Phase 1 oncology clinical research as well as the Head and Neck Group.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
